Skip to content

DoxyPEP linked to reduction in syphilis and chlamydia among gay men in Australia

Dr Michael Traeger at AIDS 2026. He is standing at a lectern talking into a microphone.

DoxyPEP halves overall syphilis cases, with possible indirect benefits for women

A person is holding a white pill and a glass of water.

Top 5 stories on HIV prevention and sexual health from CROI 2026

Dr Michael Martin at CROI 2026. He is standing behind a lectern talking into a microphone.

Vaccine fails to prevent gonorrhoea in Australian study

Professor Kate Seib at CROI 2026. She is being interviewed at the CROI conference centre.

STIs and doxyPEP at EACS: community effectiveness, gonorrhoea resistance and ‘blunted’ syphilis

Dr David Wimmersberger presenting at EACS 2025. He is talking into a microphone at a podium with a screen and panel of speakers to his left.

Resistance is a growing concern amid rising use of doxyPEP

Left to right: Jean-Michel Molina, Elizabeth Bukusi, Annie Luetkemeyer, Mark Hull and Troy Grennan at the doxyPEP symposium at IAS 2025. The panel are sitting on a stage.

Two doses of HPV vaccine as effective as the recommended three-dose schedule for women with HIV

A close-up of a nurse, wearing blue surgical gloves, about to give an injection into a person's upper arm.

Why aren’t more people with HIV accessing doxyPEP?

A person in a grey tshirt holding a white pill.

Dissent on doxyPEP: recent guidelines becoming more cautious

Africa Studio/Shutterstock.com